Publications by authors named "Marian Major"

Claim this Profile
D
Development of a recombinant membrane protein ELISA for analyzing antibody responses against SARS-CoV-2 envelope proteins.
Sylvie Chabot, Tahir Malik, Lila Saye, Martina Kosikova, Hyeog Kang, Marian Major

J Biol Chem· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combined immunization with SARS-CoV-2 spike and SARS-CoV nucleocapsid protects K18-hACE2 mice but increases lung pathology.
Jaekwan Kim, Alla Kachko, Prabhuanand Selvaraj, David Rotstein, Charles Brandon Stauft, Marian Major

NPJ Vaccines· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modeling of randomized hepatitis C vaccine trials: Bridging the gap between controlled human infection models and real-word testing.
Mary-Ellen Mackesy-Amiti, Alexander Gutfraind, Eric Tatara, Nicholson T Collier, Scott J Cotler, Marian Major

PNAS Nexus· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
4
405 nm violet-blue light inactivates hepatitis C cell culture virus (HCVcc) in ex vivo human platelet concentrates and plasma.
Joseph W Jackson, Pravin R Kaldhone, Caitlin Stewart, John Anderson, Scott MacGregor, Marian Major

Sci Rep· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Theoretical modeling of hepatitis C acute infection in liver-humanized mice support pre-clinical assessment of candidate viruses for controlled-human-infection studies.
Zhenzhen Shi, Adquate Mhlanga, Yuji Ishida, Ari Josephson, Nicholson T Collier, Marian Major

Sci Rep· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vaccine-associated respiratory pathology correlates with viral clearance and protective immunity after immunization with self-amplifying RNA expressing the spike (S) protein of SARS-CoV-2 in mouse models.
Alla Kachko, Prabhuanand Selvaraj, Shufeng Liu, Jaekwan Kim, David Rotstein, Marian Major

Vaccine· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Distinct Conformations of SARS-CoV-2 Omicron Spike Protein and Its Interaction with ACE2 and Antibody.
Myeongsang Lee, Marian Major, Huixiao Hong

Int J Mol Sci· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessing the impact of hepatitis B immune globulin (HBIG) on responses to hepatitis B vaccine during co-administration.
Iryna Zubkova, Yangqing Zhao, Qingwen Cui, Alla Kachko, Yusra Gimie, Marian Major

Vaccine· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enhanced and Potency of a T Cell Epitope in the Ebola Virus Glycoprotein Following Amino Acid Replacement at HLA-A*02:01 Binding Positions.
Sylvie Chabot, Yusra Gimie, Karam Obeid, Jaekwan Kim, Clement A Meseda, Marian E Major

J Virol· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modeling hepatitis C micro-elimination among people who inject drugs with direct-acting antivirals in metropolitan Chicago.
Eric Tatara, Alexander Gutfraind, Nicholson T Collier, Desarae Echevarria, Scott J Cotler, Marian E Major

PLoS One· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An Antigenically Diverse, Representative Panel of Envelope Glycoproteins for Hepatitis C Virus Vaccine Development.
Jordan H Salas, Richard A Urbanowicz, Johnathan D Guest, Nicole Frumento, Alexis Figueroa, Marian Major

Gastroenterology· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MULTI-OBJECTIVE MODEL EXPLORATION OF HEPATITIS C ELIMINATION IN AN AGENT-BASED MODEL OF PEOPLE WHO INJECT DRUGS.
Eric Tatara, Nicholson T Collier, Jonathan Ozik, Alexander Gutfraind, Scott J Cotler, Marian Major

Proc Winter Simul Conf· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Detection of Antibodies to HCV E1E2 by Lectin-Capture ELISA.
Marian Major, Mansun Law

Methods Mol Biol· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modeling indicates efficient vaccine-based interventions for the elimination of hepatitis C virus among persons who inject drugs in metropolitan Chicago.
Desarae Echevarria, Alexander Gutfraind, Basmattee Boodram, Jennifer Layden, Jonathan Ozik, Marian Major

Vaccine· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modeling of patient virus titers suggests that availability of a vaccine could reduce hepatitis C virus transmission among injecting drug users.
Marian Major, Alexander Gutfraind, Louis Shekhtman, Qingwen Cui, Alla Kachko

Sci Transl Med· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Determinants in the Ig Variable Domain of Human HAVCR1 (TIM-1) Are Required To Enhance Hepatitis C Virus Entry.
Alla Kachko, Maria Isabel Costafreda, Iryna Zubkova, Jerome Jacques, Kazuyo Takeda, Marian E Major

J Virol· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Qualitative differences in cellular immunogenicity elicited by hepatitis C virus T-Cell vaccines employing prime-boost regimens.
Wendy G Tan, Iryna Zubkova, Alla Kachko, Frances Wells, Heiko Adler, Marian E Major

PLoS One· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modeling HCV cure after an ultra-short duration of therapy with direct acting agents.
Ashish Goyal, Yoav Lurie, Eric G Meissner, Marian Major, Natasha Sansone

Antiviral Res· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Agent-Based Model Forecasts Aging of the Population of People Who Inject Drugs in Metropolitan Chicago and Changing Prevalence of Hepatitis C Infections.
Alexander Gutfraind, Basmattee Boodram, Nikhil Prachand, Atesmachew Hailegiorgis, Harel Dahari, Marian E Major

PLoS One· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mathematical Modeling of Hepatitis C Prevalence Reduction with Antiviral Treatment Scale-Up in Persons Who Inject Drugs in Metropolitan Chicago.
Desarae Echevarria, Alexander Gutfraind, Basmattee Boodram, Marian Major, Sara Del Valle

PLoS One· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hepatitis C: new clues to better vaccines?
Marian E Major

Gut· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antibodies to an interfering epitope in hepatitis C virus E2 can mask vaccine-induced neutralizing activity.
Alla Kachko, Sharon E Frey, Lev Sirota, Ranjit Ray, Frances Wells, Marian E Major

Hepatology· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reverse Engineering of Vaccine Antigens Using High Throughput Sequencing-enhanced mRNA Display.
Nini Guo, Hongying Duan, Alla Kachko, Benjamin W Krause, Marian E Major

EBioMedicine· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hepatitis C virus clearance correlates with HLA-DR expression on proliferating CD8+ T cells in immune-primed chimpanzees.
Iryna Zubkova, Hongying Duan, Frances Wells, Howard Mostowski, Esther Chang, Marian Major

Hepatology· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of hepatitis C virus by the cyanobacterial protein Microcystis viridis lectin: mechanistic differences between the high-mannose specific lectins MVL, CV-N, and GNA.
Alla Kachko, Sandra Loesgen, Syed Shahzad-Ul-Hussan, Wendy Tan, Iryna Zubkova, Marian E Major

Mol Pharm· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis